โšกYour ready-to-use recruitment solution: IRB-compliant, SEO-optimized website that automatically routes qualified patient leads to your clinical study (14-day free trial, then $44/mo)

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

Sponsored by Rutgers, The State University of New Jersey

Quick Self-Assessment

See if you qualify and express your interest

Preparing your pre-screening questions...

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Verified Feb 20, 2025

Phase

Clinical Trial

Sponsor

Rutgers, The State University of New Jersey

Enrollment Target

420

Start Date

Sep 2023

๐Ÿ“Š
1 of 420 participants interested
0% interest

Express Your Interest Today

Interested in learning more? Complete the form below.

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Advance Medical Science

    Contribute to groundbreaking research

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel (varies by study)

  • Help Others

    Benefit future patients

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3In-person assessment if eligible
  4. 4Begin participation

About This Study

The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.

Who Can Participate

Inclusion Criteria

English-speaking
Currently on methadone; and 4) currently smoke cigarettes.

Exclusion Criteria

Severe cognitive impairment (score \>23 on Mini Mental Status Exam) or psychosis (positive SCID Psychotic Screen)
Suicidal risk (score โ‰ฅ7 on Suicidal Behaviors Questionnaire)
Inability to attend or fully participate in intervention sessions or assessments
Previous formal mindfulness training (e.g., MBSR, MBRP) or MORE (from the R21 or R33
Currently taking smoking cessation pharmacotherapy or participating in smoking cessation counseling
Any contraindications for NRT
Currently or soon planning to be pregnant or breastfeeding.

โ“ Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility during the screening process.

Study Details

๐Ÿ“‹

Study Type

INTERVENTIONAL

๐Ÿ‘ฅ

Target Enrollment

420 participants

โšง

Gender

ALL

๐Ÿข

Sponsor

Rutgers, The State University of New Jersey

Study Locations

Choose your preferred location or select flexible during enrollment

RECRUITING

New Brunswick

New Jersey

Location available
View New Brunswick location page
RECRUITING

Salt Lake City

Utah

Location available
View Salt Lake City location page

Frequently Asked Questions

Q:What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Q:Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Q:Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Q:Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

Q:How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Still have questions? Our study coordinators are here to help.

Ready to Make a Difference?

Express your interest in this groundbreaking clinical trial

๐Ÿ”’ Secure ยท ๐Ÿฅ Expert Care

Find More Multiple Myeloma Trials by City

Browse all multiple myeloma clinical trials in these cities โ€” not just this study.

Looking for I cannot determine the primary medical condition from this data. The study title mentions "Recovery Enhancement" which suggests addiction or substance use, but the conditions listed are coded as intervention groups rather than medical conditions, and the brief summary is incomplete. Without clear condition information, I cannot provide a patient-facing medical condition. Treatment in New Brunswick?

Join others in New Jersey exploring innovative treatment options through clinical research

I cannot determine the primary medical condition from this data. The study title mentions "Recovery Enhancement" which suggests addiction or substance use, but the conditions listed are coded as intervention groups rather than medical conditions, and the brief summary is incomplete. Without clear condition information, I cannot provide a patient-facing medical condition. Treatment Options in New Brunswick, New Jersey

If you're searching for I cannot determine the primary medical condition from this data. The study title mentions "Recovery Enhancement" which suggests addiction or substance use, but the conditions listed are coded as intervention groups rather than medical conditions, and the brief summary is incomplete. Without clear condition information, I cannot provide a patient-facing medical condition. treatment in New Brunswick, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in New Brunswick, Salt Lake City and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with I cannot determine the primary medical condition from this data. The study title mentions "Recovery Enhancement" which suggests addiction or substance use, but the conditions listed are coded as intervention groups rather than medical conditions, and the brief summary is incomplete. Without clear condition information, I cannot provide a patient-facing medical condition.. All study-related care is provided at no cost to participants.

Local Sites
2 locations in New Jersey
Now Enrolling
Up to 420 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for I cannot determine the primary medical condition from this data. The study title mentions "Recovery Enhancement" which suggests addiction or substance use, but the conditions listed are coded as intervention groups rather than medical conditions, and the brief summary is incomplete. Without clear condition information, I cannot provide a patient-facing medical condition.?

Potential Benefits

  • โœ“Access to new treatment approaches before public availability
  • โœ“Close monitoring by experienced medical professionals
  • โœ“Study-related care provided at no cost
  • โœ“Contribute to medical research for I cannot determine the primary medical condition from this data. The study title mentions "Recovery Enhancement" which suggests addiction or substance use, but the conditions listed are coded as intervention groups rather than medical conditions, and the brief summary is incomplete. Without clear condition information, I cannot provide a patient-facing medical condition.

What to Expect

  • โ†’Initial screening to determine eligibility
  • โ†’Regular check-ups and monitoring visits
  • โ†’Possible compensation for time and travel
  • โ†’You can withdraw at any time

Frequently Asked Questions About This I cannot determine the primary medical condition from this data. The study title mentions "Recovery Enhancement" which suggests addiction or substance use, but the conditions listed are coded as intervention groups rather than medical conditions, and the brief summary is incomplete. Without clear condition information, I cannot provide a patient-facing medical condition. Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT06033599. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.